Search

Your search keyword '"Urologic diseases -- Drug therapy"' showing total 47 results
Start Over Descriptor "Urologic diseases -- Drug therapy"
47 results on '"Urologic diseases -- Drug therapy"'

1. The switch to OTC: Are urologic drugs next?

Author

Dmochowski, Roger

Subjects
Drug therapy, Forecasts and trends, Market trend/market analysis, Nonprescription drugs -- Forecasts and trends, Urologic diseases -- Drug therapy
Abstract

Switching a medication from prescription to over-the-counter status comes with challenges and risks, and is not always successful. In this interview, Roger Dmochowski, MD, discusses the pros and cons of [...]

Published
2018

2. Bilateral megaureters in the Adriamycin rat model

Author

Mortell, A., Fourcade, L., Solari, V., and Puri, P.

Subjects
Doxorubicin -- Dosage and administration, Urologic diseases -- Development and progression, Urologic diseases -- Diagnosis, Urologic diseases -- Drug therapy, Health
Published
2005

3. The use of botulinum toxin type A in urological procedures

Author

Lajiness, Michelle J.

Subjects
United States. Food and Drug Administration -- Powers and duties, Botulinum toxin -- Usage, Botulinum toxin -- Health aspects, Urologic diseases -- Drug therapy, Health, Health care industry
Published
2009

4. Managing patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia

Author

McNaughton-Collins, Mary and Barry, Michael J.

Subjects
Urologic diseases -- Risk factors, Urologic diseases -- Drug therapy, Prostate -- Hypertrophy, Prostate -- Complications and side effects, Prostate -- Diagnosis, Prostate -- Care and treatment, Prostate -- Research, Health, Health care industry
Abstract

To link to full-text access for this article, visit this link: http://dx.doi.org/10.1016/j.amjmed.2004.12.033 Byline: Mary McNaughton-Collins, Michael J. Barry Keywords: Benign prostatic hyperplasia; Diagnosis; Treatment Abstract: Many men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia can be managed safely and effectively by primary care providers. After a basic evaluation to exclude other diseases that may cause lower urinary tract symptoms, quantifying the degree of symptoms and bother, and perhaps making an assessment of prostate size, the primary care provider can determine which men require immediate evaluation by a urologist and which men may choose among various treatment options, including watchful waiting and various single agent or combination medication strategies. Recent information about risk factors for disease progression has also helped to inform patient decisions on which treatment option is best for the individual patient. The purpose of this review is to provide primary care providers with an approach to the management of men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia. Author Affiliation: General Medicine Division, Massachusetts General Hospital, Boston, Mass. Article History: Received 31 December 2004; Accepted 31 December 2004

Published
2005

6. Long-term efficacy and safety of PRO 160/120 (a combination of Sabal and Urtica extract) in patients with lower urinary tract symptoms (LUTS). (Short Communication)

Author

Bondarenko, Boris, Walther, Carola, Funk, Petra, Schlafke, Sandra, and Engelmann, Udo

Subjects
Saw-palmetto -- Health aspects -- Physiological aspects -- Chemical properties, Urologic diseases -- Drug therapy, Nettles -- Health aspects -- Physiological aspects -- Chemical properties, Urinary organs -- Physiological aspects -- Chemical properties -- Health aspects, Biological sciences, Health, Science and technology, Drug therapy, Chemical properties, Physiological aspects, Health aspects
Abstract

Lower urinary tract symptoms (LUTS) are a very common phenomenon in ageing males (Treagust et al., 2001; Berges et al., 2001) predominantly caused by benign prostatic hyperplasia (BPH). Prostatic enlargement [...]

Published
2003

7. Trospium chloride, oral

Subjects
Drug therapy, Complications and side effects, Dosage and administration, Trospium -- Dosage and administration -- Complications and side effects, Urologic diseases -- Drug therapy
Abstract

TROS-pee-um KLOR-ide What are other names for this medicine? Type of medicine: antispasmodic; anticholinergic Generic and brand names: trospium chloride, oral; Sanctura; Sanctura XR What is this medicine used for? [...]

Published
2010

8. Urinary tract infections

Author

Neu, Harold C.

Subjects
Urinary tract infections -- Risk factors, Urologic diseases -- Drug therapy, Health, Health care industry
Published
1992

10. Stenting the urethra after Snodgrass repair for distal hypospadias - is it necessary?

Author

Singh, J. Chandra and Kekre, Nitin

Subjects
Urologic diseases -- Case studies, Urologic diseases -- Drug therapy, Health
Abstract

Tubularized incised plate repair of distal hypospadias in toilet-trained children: should a stent be left?BJU Int. 2003;92:1003-5. El- Sherbiny MT. COMMENTS This prospective randomized study[1] was designed to evaluate the [...]

Published
2005

11. The price of prior authorization

Author

Quallich, Susanne A.

Subjects
Drug therapy, Licensing, certification and accreditation, Urologic diseases -- Drug therapy, Prescriptions (Drugs) -- Licensing, certification and accreditation
Abstract

Testosterone. Collagenase. FSH. Mirabegron. Solifenacin succinate. Darifenacin. Sildenafil, tadalafil, vardenafil ... A rogues' gallery of urologic medications, all with variable requirements for prior authorization from insurance companies. Prescription medications represent [...]

Published
2015
Full Text
View/download PDF

12. Independent Nurse: Clinical - Men's Health - Can saw palmetto benefit men's health?

Subjects
Saw-palmetto -- Health aspects -- Usage, Urologic diseases -- Drug therapy, Alternative medicine -- Usage -- Health aspects, News, opinion and commentary
Abstract

The use of supplements for male urological disease has increased, writes Dr Alyson Huntley. It can be no surprise that men's and women's use of complementary and alternative medicine (CAM) [...]

Published
2007

13. The efficacy and safety of povidone iodine in the management of chyluria

Author

Bhat, Suresh, Kishore, T.A., Govindan, Hari, Dinesan, K.M., and Cardoza, Felix

Subjects
Povidone -- Dosage and administration, Povidone -- Patient outcomes, Iodine -- Usage, Iodine -- Health aspects, Urologic diseases -- Drug therapy, Health
Abstract

Table of Contents Abstract Introduction Materials and Methods Results Discussion References Abstract Aim: To assess the efficacy and safety of povidone iodine in the management of chyluria. Materials & method: [...]

Published
2006

14. Urological disorders

Subjects
Urologic diseases -- Drug therapy, Pharmaceuticals and cosmetics industries, Drug therapy
Abstract

Urological disorders (Impotence, urinary incontinence, BPH) New drugs Product type/proposed indication (Cialis) oral phosphodiesterase-5 inhibitor; Lilly ICOS LLC treatment of erectile dysfunction and diabetes-related erectile dysfunction darifenacin selective muscarinic antagonist; [...]

Published
2001

15. The future of drug delivery in the bladder?

Author

Hanno, Philip M.

Subjects
Drug therapy, Innovations, Drug delivery systems -- Innovations, Urologic diseases -- Drug therapy
Abstract

The current issue of Urology Times highlights the report of Dr. Ken Peters' presentation at the AUA annual meeting concerning the LiRIS device (see article, page 6). This lidocaine-releasing intravesical [...]

Published
2016

16. 17A Urinary tract disorders

Subjects
Drug therapy, Complications and side effects, Dosage and administration, Analgesics -- Dosage and administration -- Complications and side effects, Urologic diseases -- Drug therapy
Abstract

AZO STANDARD Amerifit Nutrition OTC Urinary tract analgesic. Phenazopyridine HCl 95mg; tabs. Also: AZO STANDARD MAXIMUM STRENGTH OTC Phenazopyridine HCl 97.5mg; tabs. Indications: Urinary tract discomfort. Adults: 2 tabs 3 [...]

Published
2011

17. 17A Urinary tract disorders

Subjects
Drug therapy, Complications and side effects, Product information, Dosage and administration, Analgesics -- Dosage and administration -- Complications and side effects, Urologic diseases -- Drug therapy, Pharmaceutical industry -- Product information
Abstract

AZO STANDARD Amerifit Nutrition OTC Urinary tract analgesic. Phenazopyridine HCl 95mg; tabs. Also: AZO STANDARD MAXIMUM STRENGTH OTC Phenazopyridine HCl 97.5mg; tabs. Indications: Urinary tract discomfort. Adults: 2 tabs 3 [...]

Published
2011

18. 17A Urinary tract disorders

Subjects
Drug therapy, Complications and side effects, Product information, Dosage and administration, Antiseptics -- Dosage and administration -- Complications and side effects -- Product information, Phenazopyridine -- Dosage and administration -- Complications and side effects -- Product information, Urologic diseases -- Drug therapy, Antispasmodics -- Dosage and administration -- Complications and side effects -- Product information
Abstract

AZO STANDARD Amerifit Nutrition OTC Urinary tract analgesic. Phenazopyridine HCl 95mg; tabs. Also: AZO STANDARD MAXIMUM STRENGTH OTC Phenazopyridine HCl 97.5mg; tabs. Indications: Urinary tract discomfort. Adults: 2 tabs 3 [...]

Published
2011

19. 17A Urinary tract disorders

Subjects
Drug therapy, Complications and side effects, Product information, Dosage and administration, Analgesics -- Dosage and administration -- Complications and side effects -- Product information, Antiseptics -- Dosage and administration -- Complications and side effects -- Product information, Urologic diseases -- Drug therapy, Antispasmodics -- Dosage and administration -- Complications and side effects -- Product information
Abstract

AZO STANDARD OTC Amerifit Nutrition Urinary tract analgesic. Phenazopyridine HCl 95mg; tabs. Also: AZO STANDARD MAXIMUM STRENGTH OTC Phenazopyridine HCl 97.5mg; tabs. Indications: Urinary tract discomfort. Adults: 2 tabs 3 [...]

Published
2011

20. 17A Urinary tract disorders

Subjects
Drug therapy, Complications and side effects, Product information, Dosage and administration, Phenazopyridine -- Dosage and administration -- Complications and side effects -- Product information, Urologic diseases -- Drug therapy, Pharmaceutical industry -- Product information
Abstract

AZO STANDARD Amerifit Nutrition OTC Urinary tract analgesic. Phenazopyridine HCl 95mg; tabs. Also: AZO STANDARD MAXIMUM STRENGTH OTC Phenazopyridine HCl 97.5mg; tabs. Indications: Urinary tract discomfort. Adults: 2 tabs 3 [...]

Published
2011

21. 17A Urinary tract disorders

Subjects
Drug therapy, Complications and side effects, Product information, Dosage and administration, Renal agents -- Dosage and administration -- Complications and side effects, Urologic diseases -- Drug therapy, Pharmaceutical industry -- Product information
Abstract

AZO STANDARD OTC Amerifit Nutrition Urinary tract analgesic. Phenazopyridine HCl 95mg; tabs. Also: AZO STANDARD MAXIMUM STRENGTH OTC Phenazopyridine HCl 97.5mg; tabs. Indications: Urinary tract discomfort. Adults: 2 tabs 3 [...]

Published
2011

22. 19A Urinary tract disorders

Subjects
Drug therapy, Complications and side effects, Dosage and administration, Analgesics -- Dosage and administration -- Complications and side effects, Urologic diseases -- Drug therapy
Abstract

PRESCRIBING NOTES For antibiotics and antiinfectives for treating urinary tract infections see Section 11A. AZO STANDARD Amerifit Nutrition OTC Urinary tract analgesic. Phenazopyridine HCl 95mg; tabs. Also: AZO STANDARD MAXIMUM [...]

Published
2011

23. 19A Urinary tract disorders

Subjects
Drug therapy, Complications and side effects, Product information, Dosage and administration, Anti-infective agents -- Dosage and administration -- Complications and side effects -- Product information, Urologic diseases -- Drug therapy, Pharmaceutical industry -- Product information
Abstract

PRESCRIBING NOTES For antibiotics and antiinfectives for treating urinary tract infections see Section 11A. AZO STANDARD Amerifit Nutrition OTC Urinary tract analgesic. Phenazopyridine HCl 95mg; tabs. Also: AZO STANDARD MAXIMUM [...]

Published
2011

24. 19A Urinary tract disorders

Subjects
Drug therapy, Complications and side effects, Dosage and administration, Analgesics -- Dosage and administration -- Complications and side effects, Antibiotics -- Dosage and administration -- Complications and side effects, Urologic diseases -- Drug therapy
Abstract

PRESCRIBING NOTES For antibiotics and antiinfectives for treating urinary tract infections see Section 11A. AZO STANDARD Amerifit Nutrition OTC Urinary tract analgesic. Phenazopyridine HCl 95mg; tabs. Also: AZO STANDARD MAXIMUM [...]

Published
2010

25. 19A Urinary tract disorders

Subjects
Drug therapy, Complications and side effects, Dosage and administration, Renal agents -- Dosage and administration -- Complications and side effects, Urologic diseases -- Drug therapy
Abstract

PRESCRIBING NOTES For antibiotics and antiinfectives for treating urinary tract infections see Section 11A. AZO STANDARD Amerifit Nutrition OTC Urinary tract analgesic. Phenazopyridine HCl 95mg; tabs. Also: AZO STANDARD MAXIMUM [...]

Published
2010

26. 19A Urinary tract disorders

Subjects
Drug therapy, Complications and side effects, Dosage and administration, Genitourinary agents -- Dosage and administration -- Complications and side effects, Urologic diseases -- Drug therapy
Abstract

PRESCRIBING NOTES For antibiotics and antiinfectives for treating urinary tract infections see Section 11A. AZO STANDARD Amerifit Nutrition OTC Urinary tract analgesic. Phenazopyridine HCl 95mg; tabs. Also: AZO STANDARD MAXIMUM [...]

Published
2010

27. IC/BPS: agent brings glimmer of hope

Author

Hanno, Philip M.

Subjects
Drug therapy, Complications and side effects, Dosage and administration, Cyclosporins -- Dosage and administration -- Complications and side effects, Urologic diseases -- Drug therapy
Abstract

This issue of Urology Times reports on an abstract by Chade and coworkers regarding long-term follow-up of patients with refractory interstitial cystitis/bladder pain syndrome (as defined by NIDDK criteria) showing [...]

Published
2015

28. 19A Urinary tract disorders

Subjects
Urologic diseases -- Drug therapy, Analgesics -- Dosage and administration, Analgesics -- Complications and side effects, Analgesics -- Product information
Abstract

PRESCRIBING NOTES For antibiotics and antiinfectives for treating urinary tract infections see Section 11A. AZO STANDARD Amerifit Nutrition OTC Urinary tract analgesic. Phenazopyridine HCl 95mg; tabs. Also: AZO STANDARD MAXIMUM [...]

Published
2007

29. Urinary tract disorders

Subjects
AZO-Standard (Medication) -- Dosage and administration, AZO-Standard (Medication) -- Complications and side effects, Pyridium (Medication) -- Complications and side effects, Pyridium (Medication) -- Dosage and administration, Urimax (Medication) -- Dosage and administration, Urimax (Medication) -- Complications and side effects, Urised (Medication) -- Dosage and administration, Urised (Medication) -- Complications and side effects, Urispas (Medication) -- Dosage and administration, Urispas (Medication) -- Complications and side effects, Urologic diseases -- Drug therapy
Abstract

PRESCRIBING NOTES For antibiotics and antiinfectives for treating urinary tract infections see Section 11A. AZO STANDARD OTC PolyMedica Urinary tract analgesic. Phenazopyridine HCl 95mg; tabs. Indications: Urinary tract discomfort. Adults: [...]

Published
2005

30. Obstet Gynecol.: Discontinuation Rate for Bladder Medications High

Subjects
Women -- Health aspects, Patient compliance -- Reports, Urologic diseases -- Drug therapy, Parasympatholytic agents -- Dosage and administration, Business, Economics, Health care industry
Abstract

2008;112:1311-1318. [December 2008] More than hall of women prescribed anticholinergic drugs for lower urinary tract symptoms suggestive of overactive bladder discontinued treatment after six months, suggesting poor adherence to treatment, [...]

Published
2008

31. Urinary tract candidosis

Subjects
Candidiasis -- Complications, Amphotericin B -- Dosage and administration, Urologic diseases -- Drug therapy, Pyelonephritis -- Causes of, Antifungal agents -- Dosage and administration
Published
1988

32. 19A Urinary tract disorders

Subjects
Drug therapy, Complications and side effects, Product information, Dosage and administration, Analgesics -- Dosage and administration -- Complications and side effects -- Product information, Urologic diseases -- Drug therapy
Abstract

Urinary tract disorders PRESCRIBING NOTES For antibiotics and antiinfectives for treating urinary tract infections see Section 11A. AZO STANDARD OTC Amerifit Nutrition Urinary tract analgesic. Phenazopyridine HCl 95mg; tabs. Also: [...]

Published
2011

33. 19A Urinary tract disorders

Subjects
Drug therapy, Complications and side effects, Product information, Dosage and administration, Urologic diseases -- Drug therapy, Urinary anti-infective agents -- Dosage and administration -- Complications and side effects -- Product information
Abstract

PRESCRIBING NOTES For antibiotics and antiinfectives for treating urinary tract infections see Section 11A. AZO STANDARD Amerifit Nutrition OTC Urinary tract analgesic. Phenazopyridine HCl 95mg; tabs. Also: AZO STANDARD MAXIMUM [...]

Published
2010

34. 19A Urinary tract disorders

Subjects
Drug therapy, Complications and side effects, Dosage and administration, Antiseptics -- Dosage and administration -- Complications and side effects, Urologic diseases -- Drug therapy, Antispasmodics -- Dosage and administration -- Complications and side effects
Abstract

PRESCRIBING NOTES For antibiotics and antiinfectives for treating urinary tract infections see Section 11A. PYRIDIUM Warner Chilcott Rx Urinary tract analgesic. Phenazopyridine HCl 100mg, 200mg; tabs. Indications: Urinary tract discomfort. [...]

Published
2010

35. Urigen targets a population growing older

Author

Schneider, Ilene

Subjects
Pharmaceutical industry -- Target marketing, Pharmaceutical industry -- Product development, Urologic diseases -- Drug therapy, Biotechnology industry, Business
Abstract

Urigen Pharmaceuticals has concentrated on the creation and marketing of drugs for urological diseases of an aging population. These treatments are the URG101 which is designed for treating painful bladder syndrome/interstitial cystitis and URG301 which is intended for addressing urinary urgency. Results of clinical trials, in which the URG101 have been subjected to, are given.

Published
2010

36. 19A Urinary tract disorders

Subjects
Drug therapy, Complications and side effects, Dosage and administration, Renal agents -- Dosage and administration -- Complications and side effects, Urologic diseases -- Drug therapy
Abstract

PRESCRIBING NOTES For antibiotics and antiinfectives for treating urinary tract infections see Section 11A. AZO STANDARD OTC Amerifit Nutrition Urinary tract analgesic. Phenazopyridine HCl 95mg; tabs. Also: AZO STANDARD MAXIMUM [...]

Published
2010

37. ED drugs tame lower urinary tract symptoms

Author

Bates, Betsy

Subjects
Urologic diseases -- Drug therapy, Anti-impotence agents -- Dosage and administration, Health, Health care industry
Abstract

ANAHEIM, CALIF. -- Three separate PDE-5 inhibitors approved for the treatment of erectile dysfunction showed powerful effects on lower urinary tract symptoms in trials unveiled at the annual meeting of [...]

Published
2007

38. BPH meds show similar efficacy for urinary symptoms

Subjects
Tamsulosin hydrochloride -- Usage, Tamsulosin hydrochloride -- Research, Urologic diseases -- Drug therapy, Urologic diseases -- Research, Health
Abstract

BPH Meds Show Similar Efficacy for Urinary Symptoms BJU Int. 2006;97:747-751 Tamsulosin and naftopidil, two alpha-1 blockers with different affinities to the alpha-1 adrenoceptor subtypes, are similarly effective for treating [...]

Published
2006

39. 19A Urinary tract disorders

Subjects
Analgesics -- Dosage and administration, Analgesics -- Complications and side effects, Urologic diseases -- Drug therapy
Abstract

PRESCRIBING NOTES For antibiotics and antiinfectives for treating urinary tract infections see Section 11A. AZO STANDARD OTC Amerifit Nutrition Urinary tract analgesic. Phenazopyridino HCl 95mg; tabs. Indications: Urinary tract discomfort. [...]

Published
2006

40. Novel statin may benefit diabetics: results of a clinical trial suggest pitavastatin inhibits progression of nephropathy

Author

MacDougall, David S.

Subjects
Urologic diseases -- Drug therapy, Health, Pitavastatin (Medication) -- Usage
Abstract

TREATMENT WITH pitavastatin, a new statin with potent cholesterol-lowering activity, may ameliorate tubulointerstitial damage in patients with early diabetic nephropathy, according to new findings. Specifically, pitavastatin has been found to [...]

Published
2006

41. Two treatments loosen lower ureteral stones

Author

Splete, Heidi

Subjects
Nifedipine -- Dosage and administration, Urologic diseases -- Drug therapy, Medical research, Medicine, Experimental
Abstract

Patients can pass stones from the lower ureter more easily when taking deflazacort plus either nifedipine or tamsulosin, compared with patients who did not take medication, said Dr. Francesco Porpiglia [...]

Published
2004

42. BioXell raises 10.5M euros

Subjects
Index Ventures -- Contracts -- Product development -- Finance, BB Biotech -- Contracts, BioXell SpA -- Finance -- Product development -- Contracts, Inflammation -- Drug therapy, Urologic diseases -- Drug therapy, Biotechnology industry -- Product development -- Contracts -- Finance, Venture capital companies -- Contracts -- Product development, Company financing, Contract agreement, Pharmaceuticals and cosmetics industries
Abstract

Milan, Italy-based BioXell says that it has raised 10.5 million euros ($12.5 million) in financing through an extension of the series C round concluded in October 2004. TVN Capital led [...]

Published
2006

43. Recordati's urologicals disappoint

Subjects
Recordati S.p.A. -- Research, Pharmaceutical industry -- Research, Urologic diseases -- Drug therapy, Business, Pharmaceuticals and cosmetics industries
Published
1996

44. Eli Lilly reported positive results from a phase IIb trial of tadalafil for the treatment of lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH)

Subjects
Eli Lilly and Co. -- Product development, Tadalafil -- Product development, Urologic diseases -- Drug therapy, Pharmaceutical industry -- Product development, Health
Abstract

Eli Lilly reported positive results from a phase IIb trial of tadalafil for the treatment of lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH). This randomized, double-blind, [...]

Published
2008

45. A phase II study of mitoguazone and vinblastine in advanced transitional cell carcinoma of the urinary tract

Author

Boyles, Salynn

Subjects
Cancer, Vinblastine -- Evaluation, Chemotherapy -- Testing, Cisplatin -- Evaluation, Urologic diseases -- Drug therapy, Business, Health care industry
Abstract

SOURCE: Cancer, December 15, 1989; 64(12):2445-2447. A phase II Eastern Cooperative Oncology Group study of the chemotherapeutic agents mitoguazone and vinblastine suggests that neither is as effective as cisplatin in [...]

Published
1990

46. Schering-Plough launches new aminoglycoside antibiotic, 'Isepacin', in Japan

Subjects
Schering-Plough Corp. -- Product introduction, Respiratory tract diseases -- Drug therapy, Urologic diseases -- Drug therapy, Pharmaceutical industry -- Product introduction, Business, Business, general, Isepacin (Medication) -- Product introduction
Abstract

SCHERING-PLOUGH LAUNCHES NEW AMINOGLYCOSIDE ANTIBIOTIC, 'ISEPACIN', IN JAPANE ANTIBIOTIC, MADISON, N.J., April 21 /PRNewswire/ -- Schering-Plough Corporation (NYSE: SGP) today announced that Essex Nippon K.K., the company's Japanese subsidiary, has [...]

Published
1988

47. For urinary infections, what's best?

Author

Weber, Melva

Subjects
Ampicillin -- Usage, Co-trimoxazole -- Usage, Urinary tract infections -- Drug therapy, Urologic diseases -- Drug therapy, Fashion and beauty, Washington, University of. School of Medicine -- Research
Published
1988

Catalog

Books, media, physical & digital resources
See catalog results